
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18877402
[patent_doc_number] => 20240000771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS
[patent_app_type] => utility
[patent_app_number] => 18/353323
[patent_app_country] => US
[patent_app_date] => 2023-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18353323
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/353323 | Bupropion dosage forms with reduced food and alcohol dosing effects | Jul 16, 2023 | Issued |
Array
(
[id] => 19938941
[patent_doc_number] => 12311055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Compositions and methods for nanoparticle lyophile forms
[patent_app_type] => utility
[patent_app_number] => 18/346115
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8547
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18346115
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/346115 | Compositions and methods for nanoparticle lyophile forms | Jun 29, 2023 | Issued |
Array
(
[id] => 18877401
[patent_doc_number] => 20240000770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS
[patent_app_type] => utility
[patent_app_number] => 18/333785
[patent_app_country] => US
[patent_app_date] => 2023-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18333785
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/333785 | Bupropion dosage forms with reduced food and alcohol dosing effects | Jun 12, 2023 | Issued |
Array
(
[id] => 19001913
[patent_doc_number] => 20240065984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
[patent_app_type] => utility
[patent_app_number] => 18/208775
[patent_app_country] => US
[patent_app_date] => 2023-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208775
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/208775 | NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT | Jun 11, 2023 | Abandoned |
Array
(
[id] => 19472648
[patent_doc_number] => 12102711
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-10-01
[patent_title] => Drug delivery systems and methods for making and using the same
[patent_app_type] => utility
[patent_app_number] => 18/321173
[patent_app_country] => US
[patent_app_date] => 2023-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 5888
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321173
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/321173 | Drug delivery systems and methods for making and using the same | May 21, 2023 | Issued |
Array
(
[id] => 19584904
[patent_doc_number] => 20240382461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS
[patent_app_type] => utility
[patent_app_number] => 18/317360
[patent_app_country] => US
[patent_app_date] => 2023-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317360
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/317360 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS | May 14, 2023 | Pending |
Array
(
[id] => 19134500
[patent_doc_number] => 11969409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Formulations of apremilast
[patent_app_type] => utility
[patent_app_number] => 18/196718
[patent_app_country] => US
[patent_app_date] => 2023-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 22174
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18196718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/196718 | Formulations of apremilast | May 11, 2023 | Issued |
Array
(
[id] => 18610739
[patent_doc_number] => 20230277469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Implantable Device for Sustained Release of a Macromolecular Drug Compound
[patent_app_type] => utility
[patent_app_number] => 18/315618
[patent_app_country] => US
[patent_app_date] => 2023-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18315618
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/315618 | Implantable device for sustained release of a macromolecular drug compound | May 10, 2023 | Issued |
Array
(
[id] => 18769266
[patent_doc_number] => 20230364022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/300739
[patent_app_country] => US
[patent_app_date] => 2023-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18300739
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/300739 | Delayed release composition for peroral administration | Apr 13, 2023 | Issued |
Array
(
[id] => 18536204
[patent_doc_number] => 20230241292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => BONE VOID FILLER PREPARATION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/134274
[patent_app_country] => US
[patent_app_date] => 2023-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134274
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/134274 | BONE VOID FILLER PREPARATION SYSTEM | Apr 12, 2023 | Pending |
Array
(
[id] => 18566108
[patent_doc_number] => 20230256436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/296954
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296954 | Limit size lipid nanoparticles and related methods | Apr 5, 2023 | Issued |
Array
(
[id] => 18829554
[patent_doc_number] => 20230398078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => TABLET FOR ORAL SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 18/191910
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18191910
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/191910 | TABLET FOR ORAL SUSPENSION | Mar 28, 2023 | Abandoned |
Array
(
[id] => 18522893
[patent_doc_number] => 20230233542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => Methylphenidate Extended Release Chewable Tablet
[patent_app_type] => utility
[patent_app_number] => 18/184443
[patent_app_country] => US
[patent_app_date] => 2023-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18184443
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/184443 | Methylphenidate Extended Release Chewable Tablet | Mar 14, 2023 | Abandoned |
Array
(
[id] => 18762983
[patent_doc_number] => 11813363
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-14
[patent_title] => Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment
[patent_app_type] => utility
[patent_app_number] => 18/118919
[patent_app_country] => US
[patent_app_date] => 2023-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8057
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18118919
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/118919 | Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment | Mar 7, 2023 | Issued |
Array
(
[id] => 18610770
[patent_doc_number] => 20230277500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => COMPOSITIONS COMPRISING ATICAPRANT
[patent_app_type] => utility
[patent_app_number] => 18/179093
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18179093
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/179093 | COMPOSITIONS COMPRISING ATICAPRANT | Mar 5, 2023 | Abandoned |
Array
(
[id] => 18610961
[patent_doc_number] => 20230277691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => POLYMERS, SYSTEMS, AND METHODS FOR USING AND MONITORING POLYMERS FOR USE IN MEDICAL POLYMERS, IMPLANTS, AND PROCEDURES
[patent_app_type] => utility
[patent_app_number] => 18/116737
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18116737
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/116737 | POLYMERS, SYSTEMS, AND METHODS FOR USING AND MONITORING POLYMERS FOR USE IN MEDICAL POLYMERS, IMPLANTS, AND PROCEDURES | Mar 1, 2023 | Pending |
Array
(
[id] => 18836809
[patent_doc_number] => 11844866
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Gastroretentive extended release dosage form
[patent_app_type] => utility
[patent_app_number] => 18/177348
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20631
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18177348
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/177348 | Gastroretentive extended release dosage form | Mar 1, 2023 | Issued |
Array
(
[id] => 18389725
[patent_doc_number] => 20230157943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => HYDROPHOBIC TOPICAL COMPOSITIONS AND METHODS FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 18/158128
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18158128
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/158128 | Hydrophobic topical compositions and methods for producing same | Jan 22, 2023 | Issued |
Array
(
[id] => 18544187
[patent_doc_number] => 11717518
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-08-08
[patent_title] => Bupropion dosage forms with reduced food and alcohol dosing effects
[patent_app_type] => utility
[patent_app_number] => 18/157393
[patent_app_country] => US
[patent_app_date] => 2023-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5595
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18157393
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/157393 | Bupropion dosage forms with reduced food and alcohol dosing effects | Jan 19, 2023 | Issued |
Array
(
[id] => 18842505
[patent_doc_number] => 20230404909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN
[patent_app_type] => utility
[patent_app_number] => 18/154566
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154566
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154566 | MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN | Jan 12, 2023 | Abandoned |